THE LARGEST COLLECTION OF WRITING JOBS ON EARTH
Supports PDF, DOC, DOCX, TXT, XLS, WPD, HTM, HTML files up to 5 MB
dietary fiber supplement provisional patent editing I am almost finish writing a provisional patent by myself, it is about dietary fiber supplement similar to the Psyllium Fiber Supplement product here is ..
:,ActualValueFromSolar:null},{QuestionName:Job Summary,AnswerValue:JOB OVERVIEWu003cbr/u003eThe Technical Writer writes or edits a variety of comprehensive and difficult material for stylistic consistency, logic, organization, rational development of content, and emphasis. Researches, selects sources for, and ..
u003cpu003eSenior Proposal Manageru003c/pu003enu003cpu003eFounded in 1965, Telecare is a rapidly growing mental health care company dedicated to making a difference for our clients, the community, and our employees. We offer an array ..
About AbbVieAbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on ..
u003cpu003eFounded in 1965, Telecare is a rapidly growing mental health care company dedicated to making a difference for our clients, the community, and our employees. We offer an array of mental ..
See yourself at Twilio Join the team as our next Content Marketing Specialist, Content Writer. Who we are & why we’re hiring Twilio powers real-time business communications and data solutions that ..
u003cpu003eu003cstrongu003ePOSITION SUMMARYu003c/strongu003eu003cbru003eThe Proposal Manager is responsible for developing and writing proposals for large (u003e$1 million), complex bids. This position plays a key role in a multidisciplinary proposal development team to create ..
OPPORTUNITYMammoth is currently seeking a talented and detail-oriented Research Associate II to join our therapeutic genome editing team. The successful candidate will work closely and collaboratively with colleagues to design/develop, perform ..
About IDEAYA Biosciences:IDEAYA Biosciences (NASDAQ: IDYA) is a public, clinical-stage synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using DNA ..